A large amount of evidence supports the widespread use of transcatheter aortic valve
replacement (TAVR) among patients who are at low to intermediate risk for surgery …

Background The roles of anticoagulation alone or with an antiplatelet agent after
transcatheter aortic-valve implantation (TAVI) have not been well studied. Methods We …

The performance of transcatheter aortic valve replacement has expanded considerably
during the past decade. Technological advances and refinement in implantation techniques …

Aims Antithrombotic therapy after transcatheter aortic valve implantation (TAVI) is highly
controversial and guideline recommendations are not evidence based. We assessed …

Transcatheter aortic valve implantation (TAVI) has emerged as an important alternative to
surgical aortic valve repair (SAVR) for patients with severe aortic stenosis. This rapidly …

Transcatheter aortic valve implantation (TAVI) is a minimally invasive procedure, which is
used frequently in patients with symptomatic severe aortic valve stenosis. Most patients …

Transcatheter aortic valve implantation (TAVI) is the standard of care for symptomatic severe
aortic stenosis. Antithrombotic therapy is required after TAVI to prevent thrombotic …

This review provides a comprehensive overview of the available data on antithrombotic
therapy after transcatheter aortic valve implantation (TAVI). In the absence of large …

Objectives We aimed to investigate the efficacy and safety of different antithrombotic
strategies in patients undergoing transcatheter aortic valve implantation (TAVI) using …

Abstract Transcatheter Aortic Valve Replacement (TAVR) marks a significant advancement
in treating aortic stenosis (AS), especially for patients with high surgical risks. This concise …